Australia's EBR Systems jumps on filing application for heart treatment
Tue 04:42
BUZZ-Australia's EBR Systems jumps on filing application for heart treatment ** Shares of EBR Systems EBR.AX rose nearly 7% to A$0.165, their biggest intraday pct gain since Oct 13
** Wireless cardiac pacing system provider says it has applied to Therapeutic Goods Administration for inclusion of WiSE System on Australian Register of Therapeutic Goods (ARTG)
** WiSE System inclusion on ARTG allows EBR to offer it to Australian clinicians and heart patients, helping commercialize the treatment
** WiSE System is the only wireless, endocardial (inside the heart) pacing system in clinical use for stimulating the heart’s left ventricle
** YTD, stock down 81.5%
(Reporting by Aamir Sheik Khalid in Bengaluru)
Recent news on EBR Systems
See all newsAustralia's EBR Systems jumps on filing application for heart treatment
Brief: EBR Systems Submits TGA ARTG Application For Wise® System
Australia's EBR Systems hits record low on weak third-quarter revenue outlook
Brief: EBR Systems Forecasts Q3 2026 Revenue Of US$2.4 MLN To US$2.5 MLN
Brief: EBR Systems Announces Its Plan To Submit A Changes For Supplements To FDA In Q4 2026